Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Lund, Sweden – 2 July, 2013 – BioInvent International AB (OMXS: BINV) today announces that it has signed an extension to its 2009 license agreement with Mitsubishi Tanabe Pharma Corporation for the development of antibodies from BioInvent’s n-CoDeR® library. Under the terms of the extension, Mitsubishi Tanabe will continue to have access to BioInvent’s discovery and development technology platform for a further two years and can develop up to eight antibody programmes.
Help employers find you! Check out all the jobs and post your resume.
